Understand how GLP-1 drugs actually work, what the trials really show, the side effects and trade-offs, and what changed in 2026, explained clearly, without hype or a sales pitch.
The best way to understand GLP-1 medications is to learn the biology first, what the GLP-1 hormone does to appetite, blood sugar, and digestion, and then look at how drugs like semaglutide and tirzepatide amplify that, what the clinical trials actually show, and what the real side effects and trade-offs are. LearnAI explains all of this in plain language, including 2026 developments like oral GLP-1 options. It is educational, not medical advice: these are prescription drugs, and any decision about taking, starting, or stopping one belongs with your prescribing clinician.
GLP-1 medications are the most talked-about drugs in years, and the conversation is a mess of miracle stories, side-effect horror stories, and marketing from every direction. Underneath all of it is genuinely interesting science, a gut hormone, a class of drugs that amplifies it, and a body of clinical-trial evidence that's actually quite strong for what these drugs are approved to do.
LearnAI teaches you that science from the ground up. You'll learn what the GLP-1 hormone does naturally, how semaglutide, tirzepatide, and the newer agents build on it, what the major trials measured and found, and how to think clearly about benefits versus side effects and cost. When something changed recently, like the arrival of oral options in 2026, it explains what that actually means rather than repeating a headline.
One thing stays front and center: this is education, not medical advice. GLP-1s are powerful prescription medications with real side effects and contraindications. This course can help you understand them and ask your doctor better questions, but it cannot prescribe, dose, or decide anything for you. Starting, changing, or stopping one of these drugs is a conversation for your prescribing clinician.
5 weeks at your own pace, roughly 3 hours per week · built by LearnAI, adjusted to your level and goals
This is an example of the course plan LearnAI generates — yours will be personalized from your first message.
Start with the biology the drugs are built on, the natural gut hormone GLP-1 and what it does to appetite and blood sugar.
See how the drugs turn a short-lived hormone into a once-weekly or oral medication, and meet the main agents.
Look at the real clinical evidence for weight, diabetes, and cardiovascular outcomes, and how to read those numbers.
Understand the downsides honestly, the common GI effects, the more serious warnings, and muscle-loss concerns.
Get current: the newer oral agents, higher-dose options, access and cost issues, and how to read new approvals.
Turn understanding into good questions, how to weigh these drugs for a real situation and what to bring to a clinician.
These drugs are reshaping how medicine approaches obesity, diabetes, and increasingly heart and metabolic health, and they're now common enough that most people know someone taking one. Understanding how they actually work turns a confusing flood of anecdotes and ads into something you can reason about, whether the topic comes up with your own doctor or across the dinner table.
2026 has been an especially busy year. Oral GLP-1 options expanded access beyond weekly injections, higher-dose formulations arrived, and the pipeline kept growing. New indications beyond weight and diabetes continued to be studied. Following any of this intelligently means understanding the underlying mechanism first, otherwise every new approval is just another headline you have to take on faith.
Once you understand what the GLP-1 hormone naturally does to appetite and blood sugar, every drug in the class makes sense as a variation on that theme. LearnAI builds that foundation first, so semaglutide, tirzepatide, and the newer agents aren't just brand names to memorize.
The headline numbers on these drugs are real but easy to misread. LearnAI walks through what the major trials measured, what average weight-loss or blood-sugar figures actually mean, and why individual results vary, so you can interpret a claim instead of just reacting to it.
This isn't a sales pitch. LearnAI covers the common GI effects, the serious warnings and contraindications, the muscle-loss concern, and what the evidence says about stopping, the trade-offs, not just the upside, because that's what actually understanding a drug requires.
GLP-1s are powerful medications with real risks and contraindications. This course helps you understand them and ask better questions, but it does not prescribe, dose, or decide anything. Starting, changing, or stopping one is strictly a conversation for your prescribing clinician.
They mimic and extend a natural gut hormone called GLP-1, which your body releases after eating. That hormone reduces appetite, slows how fast the stomach empties, and helps regulate blood sugar. The drugs are engineered to do the same thing but last much longer, from minutes to a full week, which is why a weekly injection or daily pill can meaningfully reduce hunger and improve blood-sugar control.
Semaglutide acts on the GLP-1 receptor alone, while tirzepatide acts on two receptors, GLP-1 and GIP, which in trials has generally produced somewhat greater weight loss on average. Both are well-studied prescription medicines with overlapping but not identical indications and side-effect profiles. Which, if either, is appropriate for a given person is a medical decision, not something a course can answer for you.
As of 2026, oral options expanded beyond the original injectable drugs, including newer agents designed as pills rather than weekly shots. This widened access for people who prefer not to inject. The details of formulations, doses, and who they suit are exactly the kind of thing to confirm with a prescribing clinician, since availability and appropriateness vary.
The most common are gastrointestinal, nausea, vomiting, diarrhea, or constipation, especially early on and when doses increase, largely because the drugs slow digestion. There are also more serious warnings and contraindications that apply to specific people, plus concerns about losing muscle along with fat. This course explains these in depth, but whether any of them apply to you is a question for your doctor.
Because these drugs work by continuously suppressing appetite, studies have generally shown that appetite returns and much of the lost weight tends to come back when people stop, unless other changes are sustained. That's part of why they're often discussed as long-term treatments rather than short courses. The right approach for an individual, including how and whether to stop, is a medical decision for a prescribing clinician.
No. Everything here is educational, designed to help you understand how GLP-1 medications work and ask your doctor sharper questions. It does not prescribe, recommend doses, or account for your health history, other medications, or contraindications. These are prescription drugs, and any decision to start, change, or stop one belongs with your prescribing clinician.
Absolutely. LearnAI starts with the basic biology in plain language and builds up, checking your understanding as it goes. You don't need any science background, just a willingness to ask questions. By the end you'll understand the class well enough to follow the news and have a much more informed conversation with a clinician.
Tell LearnAI your goal and your level. It builds your course and starts teaching in under a minute — free, no account needed.
Start Learning Free — No Account Needed